SCHEMBL14097701

SCHEMBL14097701

CCNC(=O)Nc1nc2cc(-c3ccccc3)cc(C(=O)O)c2o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 5/20 0.48
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MTNR1A P48039 1/20 0.43
▸ MTNR1B P49286 1/20 0.43
▸ MAPK1 P28482 2/20 0.41
▸ PIK3CA P42336 2/20 0.41
▸ MAPK8 P45983 2/20 0.41
▸ MAPK9 P45984 2/20 0.41
▸ MAPK10 P53779 2/20 0.41
▸ FGFR1 P11362 1/20 0.41
▸ SRC P12931 1/20 0.41
▸ DHODH Q02127 1/20 0.41
▸ GSK3A P49840 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14395422 0.88 ABL1 (0.47) ABL1KDM4EALDH1A1HPGDMTNR1A
SCHEMBL14097711 0.87 ABL1 (0.49) ABL1KDM4EALDH1A1HPGDMTNR1A
SCHEMBL14097679 0.80 ABL1 (0.59) ABL1KDM4EALDH1A1PIK3CANPC1
SCHEMBL14097683 0.75 ABL1 (0.52) ABL1
SCHEMBL14097694 0.73 ABL1 (0.52) ABL1
SCHEMBL14395390 0.73 ABL1 (0.41) ABL1
SCHEMBL14097684 0.72 ABL1 (0.41) ABL1
SCHEMBL14097693 0.72 ABL1 (0.43) ABL1GSK3BMEN1MAPTKMT2A
SCHEMBL14097708 0.72 ABL1 (0.48) ABL1FGFR1SRCNPC1RAB9A
SCHEMBL14097686 0.71 ABL1 (0.40) ABL1MAPK1PIK3CAMAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
EP-1341769-B1 BACTERIAL GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2007-10-17 — — EP disclosed
Send feedback